Innovator and market leader in variable-rate contrast injection systems for cardiac and vascular angiography selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, February 18, 2008 – clinivation, Inc. announced today that ACIST Medical Systems, Inc., division of the Bracco Group, has selected clinivation WorldView® Online Regulatory Intelligence web service.
“We are delighted to add ACIST Medical Systems to our growing list of clients who have selected clinivation WorldView as their source for regulatory intelligence,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
“With its continuous focus on innovation, ACIST regulatory management understands the importance of staying up to date with ever-changing regulations,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About ACIST Medical Systems, Inc.
ACIST is a world leader in contrast delivery solutions for the imaging field, dedicated to advancing the art of angiography through research and development of new products and technologies – supporting today’s needs and anticipating those of tomorrow. More than four million people around the world have had cardiovascular angiographic procedures using an ACIST system, now at over 1 million annually – and growing. ACIST systems are widely proven in the global health care arena, with clinical usage in over 30 countries and in many world-renowned centers, as well as in community hospitals and university settings.
For more information, visit www.acist.com.
About Bracco Group
The Bracco Group is a worldwide integrated Healthcare Group with annual turnover of about 900 million Euro – around 60% of which is from foreign sales and is one of the world leading companies in the imaging agent business through Bracco Imaging SpA.
Bracco SpA, holding company of the Bracco Group, also markets Ethical and OTC pharmaceutical products and healthcare services in Italy, as well as Advanced Medical Technology systems on a world wide basis through the Bracco AMT companies, ACIST Medical Systems, based in Minneapolis, and Volume Interactions of Singapore.
Bracco is present in approximately 80 countries both directly and through joint-ventures or affiliates, and currently employs more than 2,300 people worldwide over 300 of which are dedicated to R&D, Medical and Regulatory Affairs.
For information about Bracco, please visit www.bracco.com.
